These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8358000)

  • 21. Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo--effects of oxygen tension and glutathione.
    Morrow JD; Roberts LJ; Daniel VC; Awad JA; Mirochnitchenko O; Swift LL; Burk RF
    Arch Biochem Biophys; 1998 May; 353(1):160-71. PubMed ID: 9578611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro.
    Lynch SM; Morrow JD; Roberts LJ; Frei B
    J Clin Invest; 1994 Mar; 93(3):998-1004. PubMed ID: 8132786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of an F2-isoprostane in vascular smooth muscle cells by elevated glucose and growth factors.
    Natarajan R; Lanting L; Gonzales N; Nadler J
    Am J Physiol; 1996 Jul; 271(1 Pt 2):H159-65. PubMed ID: 8760171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatorenal syndrome.
    Cárdenas A; Gines P
    Clin Liver Dis; 2006 May; 10(2):371-85, ix-x. PubMed ID: 16971267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatorenal syndrome: a dreaded complication of end-stage liver disease.
    Cárdenas A
    Am J Gastroenterol; 2005 Feb; 100(2):460-7. PubMed ID: 15667508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of isoprostanes and prostanoids on porcine small intestine.
    Unmack MA; Rangachari PK; Skadhauge E
    J Pharmacol Exp Ther; 2001 Feb; 296(2):434-41. PubMed ID: 11160628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of the isoprostane 8-epi-prostaglandin F2alpha in vitro and in vivo via the cyclooxygenases.
    Klein T; Reutter F; Schweer H; Seyberth HW; Nüsing RM
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1658-65. PubMed ID: 9316884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond.
    Moreau R; Lebrec D
    Hepatology; 2006 Mar; 43(3):385-94. PubMed ID: 16496352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of hepatorenal syndrome.
    Kiser TH; Maclaren R; Fish DN
    Pharmacotherapy; 2009 Oct; 29(10):1196-211. PubMed ID: 19792993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry.
    Mori TA; Croft KD; Puddey IB; Beilin LJ
    Anal Biochem; 1999 Mar; 268(1):117-25. PubMed ID: 10036170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatorenal syndrome.
    Biswas KD; Jain AK
    Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatorenal syndrome: new perspectives in pathophysiology and management.
    Kes P
    Acta Med Croatica; 2000; 54(4-5):165-73. PubMed ID: 11379481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of prostaglandin synthesis in cultured liver cells by CCl4.
    Johnston DE; Kroening C
    Hepatology; 1996 Sep; 24(3):677-84. PubMed ID: 8781342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New treatments of hepatorenal syndrome.
    Arroyo V; Terra C; Ginès P
    Semin Liver Dis; 2006 Aug; 26(3):254-64. PubMed ID: 16850375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hepatorenal syndrome.
    Munoz SJ
    Med Clin North Am; 2008 Jul; 92(4):813-37, viii-ix. PubMed ID: 18570944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes.
    Morrow JD; Minton TA; Mukundan CR; Campbell MD; Zackert WE; Daniel VC; Badr KF; Blair IA; Roberts LJ
    J Biol Chem; 1994 Feb; 269(6):4317-26. PubMed ID: 8307999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo.
    Morrow JD; Minton TA; Badr KF; Roberts LJ
    Biochim Biophys Acta; 1994 Jan; 1210(2):244-8. PubMed ID: 8280777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The isoprostanes: their quantification as an index of oxidant stress status in vivo.
    Morrow JD
    Drug Metab Rev; 2000; 32(3-4):377-85. PubMed ID: 11139135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prostaglandin F2 alpha and renal hypertension].
    Milanov S; Belovezhdov N; Milkov V; Gurev I; Kiperova B
    Vutr Boles; 1981; 20(6):54-8. PubMed ID: 6950590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.